LOPD
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE) (NCT04093349) | Spark Therapeutics, Inc. | 2020-10-01 |
| Neutralizing Antibody Seroprevalence Study With a Retrospective Component in Participants With Late-Onset Pompe Disease (NCT03893240) | Spark Therapeutics, Inc. | 2019-06-12 |
Track LOPD automatically
Every clearance here is in the API, with alerts when new ones post.